Eliseo Castillo named DEI associate director at UNM Cancer Center

UNM CCC receives three-year reaccreditation from the Commission on Cancer

The University of New Mexico Comprehensive Cancer Center has received reaccreditation from the Commission on Cancer, a quality program of the American College of Surgeons.

November 01, 2024

Vol.50 No.41

In Brief

Chapman-Davis, Romero Arenas, and Guzman named to Meyer Cancer Center inaugural DEI leadership team

The Sandra and Edward Meyer Cancer Center of Weill Cornell Medicine and New York-Presbyterian Hospital has appointed a trio of physicians and researchers to oversee the center’s first Office of Diversity Equity and Inclusion: Eloise Chapman-Davis, Minerva A. Romero Arenas, and Monica L. Guzman.

September 20, 2024

Vol.50 No.35

Drugs & Targets

CHMP adopts positive opinion of zolbetuximab for advanced gastric and gastroesophageal junction cancer

The European Medicines Agency’s Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion of zolbetuximab, recommending the approval of it in the European Union.

August 02, 2024

Vol.50 No.31

Guest Editorial

Cancer centers, health providers should clearly signal that they welcome LGBTQI+ patients

So far in 2024, 516 anti-queer bills have been introduced in state legislatures across the country, part of a coordinated effort where bills getting traction in one state are soon parroted by legislators in others.

June 14, 2024

Vol.50 No.24

By NFN Scout

Most cancer centers provide paltry resources for meeting NCI’s CCSG mandate to enhance diversity, study shows

Directors of NCI-designated cancer centers are facing a new set of challenges in a polarizing, high-stakes election year.

June 07, 2024

Vol.50 No.23

By Matthew Bin Han Ong

Conversation with The Cancer Letter

Fred Hutch’s Christopher Li: Cancer centers should commit more resources to meet NCI’s Plan to Enhance Diversity requirements

Christopher Li, the Helen G. Edson Endowed Chair for Breast Cancer Research at Fred Hutchinson Cancer Center, understands what it means to be an underrepresented minority at each stage of his academic career.